Studies have indicated that SNHG16 knockdown can inhibit the proliferation of various malignant tumors, including renal clear-cell carcinoma, colorectal cancer, neuroblastoma, and osteosarcoma, while promoting apoptosis [25,26,27,28]. This evidence concerns the gene SNHG16 and neuroblastoma.